Inhibitory effect of ARHI on pancreatic cancer cells and NF-κB activity

Molecular Medicine Reports

Volumn 7, Issue 4, 2013, Pages 1180-1184

  Hu, Yi Qun ^a   Si, Li Juan ^a   Ye, Zhen Shi ^a   Lin, Zhen He ^a   Zhou, Jing Ping ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Apoptosis; ARHI; Cell cycle; NF B; Proliferation

Indexed keywords

APLASIA RAS HOMOLOG MEMBER I PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PANCREAS CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NF-KAPPA B; PANCREATIC NEOPLASMS; PHOSPHORYLATION; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84875245431     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1342     Document Type: Article

References (23)

1. Yu Y, Xu F, Peng H, et al: NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA 96: 214-219, 1999.
2. Herreros-Villanueva M, Hijona E, Cosme A and Bujanda L: Spontaneous regression of pancreatic cancer: real or a misdiagnosis? World J Gastroenterol 18: 2902-2908, 2012.
3. Strimpakos A, Saif MW and Syrigos KN: Pancreatic cancer: from molecular pathogenesis to targeted therapy. Cancer Metastasis Rev 27: 495-522, 2008.
4. Hisatomi H, Nagao K, Wakita K and Kohno N: ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis. Oncology 62: 136-140, 2002.
5. Lu Z, Luo RZ, Lu Y, et al: The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 118: 3917-3929, 2008.
6. Feng WU Marquez R, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y and Bast RC Jr: Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 112: 1489-1502, 2008.
7. Weber F, Aldred MA, Morrison CD, et al: Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. J Clin Endocrinol Metab 90: 1149-1155, 2005.
8. Riemenschneider MJ, Reifenberger J and Reifenberger G: Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss. Int J Cancer 122: 2503-2510, 2008.
9. Amaravadi RK: Autophagy-induced tumor dormancy in ovarian cancer. J Clin Invest 118: 3837-3840, 2008.
10. Lu X, Qian J, Yu Y, Yang H and Li J: Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest. Oncol Rep 22: 635-640, 2009.
11. Yang H, Lu X, Qian J, et al: Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells. Mol Med Rep 3: 581-587, 2010.
12. Wickremasinghe RG, Prentice AG and Steele AJ: p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. Leukemia 25: 1400-1407, 2011.
13. Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C and Chiao PJ: Function of nuclear factor kappaB in pancreatic cancer metastasis. Clin Cancer Res 9: 346-354, 2003.
14. Li Q and Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734, 2002.
15. Hayden MS and Ghosh S: Signaling to NF-kappaB. Genes Dev 18: 2195-2224, 2004.
16. Ma X, Yang L, Xiao L, et al: Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression. PLoS One 6: e24647, 2011.
17. Perona R and Sánchez-Pérez I: Control of oncogenesis and cancer therapy resistance. Br J Cancer 90: 573-577, 2004.
18. Jung S, Yi L, Kim J, Jeong D, Oh T, Kim CH, Kim CJ, Shin J, An S and Lee MS: The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer. Mol Cells 31: 405-411, 2011.
19. Janssen EA, Øvestad I, Skaland I, Søiland H, Gudlaugsson E, Kjellevold KH, Nysted A, Søreide JA and Baak JP: LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer. Cell Oncol 31: 335-343, 2009.
20. Freise C, Ruehl M, Erben U, et al: A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines. BMC Complement Altern Med 11: 39, 2011.
21. Edderkaoui M, Odinokova I, Ohno I, Gukovsky I, Go VL, Pandol SJ and Gukovskaya AS: Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol 14: 3672-3680, 2008.
22. MacKenzie L, McCall P, Hatziieremia S, et al: Nuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor. Hum Pathol 43: 1491-1500, 2012.
23. Aggarwal BB and Sung B: NF-κB in cancer: a matter of life and death. Cancer Discov 1: 469-471, 2011.